From: Serious limitations of the QTL/Microarray approach for QTL gene discovery
 | Phenotype | QTL Mapping | Microarray Experiment | References | |||
---|---|---|---|---|---|---|---|
 |  | Design | Strains | Design | Tissues | Platform |  |
 | Targeted custom arrays | ||||||
 | Hypertension | Congenic | DS, LEW | Congenic | Kidney | Custom/ TIGR | [43] |
 | Hypertension | F2 | DS, LEW | Parental | Kidney | RT-PCR | [31] |
 | Whole-Genome arrays |  |  |  |  |  |  |
• | Aerobic running capacity | Congenic | DS, DR | Parental | Kidney | RGU34 | |
 | Alcohol addiction | Congenic | iP, iNP | Congenic | NAC, FC, ABR, hippocampus, striatum | RG230v2 | [97] |
 | Hypertension | F2 | SBH/y, SBN/y | Parental | Kidney | RAE230 | |
• | Hypertension | Congenic | DS, LEW | Congenic | Kidney | RGU34 | [30] |
• | Hypertension | Congenic | DS, DR | Congenic | Kidney | RGU34 | |
• | Hypertension | Congenic | SHRSP, WKY | Congenic | Kidney | RGU34 | [44] |
 | Hypertension | F2 | DS, LEW | Parental | Kidney | RAE230 | [32] |
 | Hypertension | F2 | DS, LEW | Parental | Kidney, adrenal gland, liver, brain | RG230v2 | [33] |
• | Kidney stones | Congenic | GHS, WKY | Congenic | Kidney, SI, FOC | RAE230 | [37] |
 | Metabolic syndrome | Congenic | SHR, WKY | Congenic | EWAT | Spotted | [27] |
 | Hypertension | Congenic | DS, DR | Parental | Kidney | GF 300 | [40] |